BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology

Contributed by: Business Wire

Logo

Images

Business Wire embedded0

Tags

Oncology

Health

Research

Pharmaceutical

Science

Biotechnology

Name Change and Switzerland Redomiciliation

More Like This

(Graphic: Business Wire)

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

BeiGene to Present at the RBC Capital Markets Global Healthcare Conference

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia

BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®